Venrock adds $500M to healthcare investing strategy after outlining 10th fund in January

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Novo Holdings acquires Catalent for $16.5bn – Pharmaceutical Technology

Share this article Novo Holdings, the Novo Nordisk Foundation’s holding and investment company, announced plans for a $16.5bn acquisition of Catalent. Credit: NurPhoto / Getty

February 5, 2024

J&J expands atopic dermatitis scope with $1.25bn Numab antibody purchase – Pharmaceutical Technology

Johnson & Johnson has inked its second deal this month in the dermatology space, targeting Numab’s bispecific antibody. Credit: Michael Vi via Shutterstock. Johnson &

May 28, 2024

Researchers find a promising approach to remove amyloid plaques in Alzheimer’s disease

Alzheimer’s disease starts with a sticky protein called amyloid beta that builds up into plaques in the brain, setting off a chain of events that

April 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.